PEP Enrollment at Baseline | 12-month After Baseline | Change over Time (n = 179) | ||||
---|---|---|---|---|---|---|
HRQOL | Mean | 95%CI | P-value* | |||
SF-12v2 | ||||||
PF | 87.3 ± 22.9 | 88.3 ± 20.1 | 1.2 ± 21.5 | (−1.9, 4.4) | 0.440 | |
RP | 89.5 ± 20.1 | 89.5 ± 20.5 | −0.1 ± 20.7 | (−3.1, 3.0) | 0.964 | |
BP | 81.4 ± 28.7 | 86.0 ± 23.9 | 6.0 ± 28.5 | (1.9, 10.2) | 0.005 | |
GH | 40.7 ± 25.0 | 36.5 ± 23.7 | −3.6 ± 29.2 | (−7.9, 0.6) | 0.095 | |
VT | 71.3 ± 26.5 | 74.0 ± 17.5 | 3.7 ± 25.5 | (0.0, 7.4) | 0.052 | |
SF | 91.3 ± 21.2 | 92.3 ± 19.3 | 1.0 ± 22.1 | (−2.3, 4.2) | 0.560 | |
RE | 88.5 ± 19.1 | 90.8 ± 16.3 | 2.7 ± 16.9 | (0.2, 5.1) | 0.034 | |
MH | 79.9 ± 18.1 | 81.0 ± 15.9 | 0.5 ± 17.2 | (−2.1, 3.0) | 0.706 | |
PCS | 49.1 ± 8.9 | 49.0 ± 7.7 | 0.4 ± 8.5 | (−0.9, 1.6) | 0.548 | |
MCS | 56.4 ± 9.5 | 57.2 ± 7.4 | 0.8 ± 8.7 | (−0.5, 2.1) | 0.229 | |
SF-6D | 0.847 ± 0.148 | 0.869 ± 0.135 | 0.026 ± 0.124 | (0.008, 0.044) | 0.006 |